Clinical trial
Clinical Estradiol Trial in Women With Schizophrenia
NCT00206570 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00206570 |
|---|---|
| Title | Clinical Estradiol Trial in Women With Schizophrenia |
| Official title | Double Blind Study of Estradiol Plus Neuroleptic Versus Placebo Plus Neuroleptic in the Treatment of Psychotic Symptoms in Women With Schizophrenia |
| Lead sponsor | Bayside Health, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression Stanley Medical Research Institute National Health and Medical Research Council, Australia |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder |
| Intervention type | Drug |
| Interventions | Estradiol |
| Enrollment | 100 |
| Start date | Jan 1, 2001 |
| Primary completion | Dec 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Sep 21, 2005 |
| Last update posted | Feb 4, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: